Skip to content
Life Sciences Seed Founded 2018

Pencil Biosciences

Pencil Biosciences is a provider of gene-editing technology. It is developing an innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases. Founded in 2018, headquartered in Alderley Edge, United Kingdom. The company has raised $10.4M in funding at the seed stage. The team comprises 17 (Jun 30, 2026) employees.…

📍 Alderley Edge, United Kingdom · Genomics

Funding snapshot

Last roundSeed
Amount$10M
Date16 August 2023
Total raised$10M
Valuation14,300,585 (Aug 16, 2023)
Team size17

About

Pencil Biosciences is a provider of gene-editing technology. It is developing an innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases. Founded in 2018, headquartered in Alderley Edge, United Kingdom. The company has raised $10.4M in funding at the seed stage. The team comprises 17 (Jun 30, 2026) employees. Pencil Biosciences operates in the Genomics sector. The company focuses on Gene Editing. Notable investors include o2h ventures, UK Innovation Science & Seed Fund, The GM&C Life Sciences Fund, o2h group, Catapult Ventures, Octopus Ventures, among others. The company has a team of 17 employees.

Business model

Genomics > Enabling Technologies > Technology Platforms > Gene Editing

Founders & team highlights

Serial Founder

Team background

College Wise > Imperial College London

Institutional investors

o2h ventures UK Innovation Science & Seed Fund The GM&C Life Sciences Fund o2h group Catapult Ventures Octopus Ventures Northern Gritstone Martlet Capital Syndicate Room Future Planet Capital Prism General Partner Jonathan Milner Martin Quibell Paul Riverslatham Jonathan Moore

Latest coverage

No articles yet.

Raising like Pencil Biosciences?

Analyze your pitch deck before your next raise.

Analyze My Deck →